Brief: Galera To Present Supplemental Analysis Of Phase 3 Trial At European Congress On Head And Neck Oncology
10/03/2023 14:07
March 10 (Reuters) - Galera Therapeutics Inc GRTX.O :
* GALERA ANNOUNCES PRESENTATION OF SUPPLEMENTAL ANALYSIS OF
PHASE
3 ROMAN TRIAL AT EUROPEAN CONGRESS ON HEAD AND NECK ONCOLOGY
Source text for Eikon: ID:nGNX7G1WMw
Further company coverage: GRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galera Therapeutics
See all newsBrief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement